Cargando…

Patient adherence issues in the treatment of hepatitis C

The current standard-of-care treatments for chronic hepatitis C, based on a bitherapy that combines peginterferon alpha-2a or -2b and ribavirin for all genotypes, and on a triple therapy with the addition of an antiprotease specifically for genotype 1, are associated with a limited adherence that de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larrey, Dominique, Ripault, Marie-Pierre, Pageaux, Georges-Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043798/ https://www.ncbi.nlm.nih.gov/pubmed/24920888 http://dx.doi.org/10.2147/PPA.S30339

Ejemplares similares

Quality of life in patients with chronic hepatitis C infection: Severe comorbidities and disease perception matter more than liver-disease stage
por: Cossais, Sabrina, et al.
Publicado: (2019)

Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody
por: Maylin, Sarah, et al.
Publicado: (2009)

Cytokine Response Associated with Hepatitis C Virus Clearance in HIV Coinfected Patients Initiating Peg Interferon-α Based Therapy
por: Nguyen, Truong Tam, et al.
Publicado: (2016)

Eighth Major Clade for Hepatitis Delta Virus
por: Le Gal, Frédéric, et al.
Publicado: (2006)

Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France
por: Marcellin, Patrick, et al.
Publicado: (2016)

Psychosocial Issues in Patients with Chronic Hepatitis B and C
por: ENESCU, AURELIA, et al.
Publicado: (2014)

Hepatotoxicity of Drugs Used in Multiple Sclerosis, Diagnostic Challenge, and the Role of HLA Genotype Susceptibility
por: Meunier, Lucy, et al.
Publicado: (2023)

Medication adherence issues in patients treated for COPD
por: Restrepo, Ruben D, et al.
Publicado: (2008)

Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism
por: Kneeland, Patrick P, et al.
Publicado: (2010)

Long‐term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia
por: Larrey, Dominique, et al.
Publicado: (2022)

Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts – 2016
por: Halota, Waldemar, et al.
Publicado: (2016)

Methodological Issues in Treatment Adherence Studies
por: Upadhyay, Ravi Prakash, et al.
Publicado: (2012)

Long-Term Effectiveness, Safety, and Patient-Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study
por: Roche, Bruno, et al.
Publicado: (2022)

Management of multiple sclerosis in adolescents – current treatment options and related adherence issues
por: Mah, Jean K, et al.
Publicado: (2010)

Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C: Open Issues and Future Perspectives
por: Chae, Hee Bok, et al.
Publicado: (2013)

SILEN-C3, a Phase 2 Randomized Trial with Faldaprevir plus Pegylated Interferon α-2a and Ribavirin in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients
por: Dieterich, Douglas, et al.
Publicado: (2014)

Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs
por: Teschke, Rolf, et al.
Publicado: (2016)

The use of technology-based adherence monitoring in the treatment of hepatitis C virus
por: Adje, Yeba H., et al.
Publicado: (2022)

Profile of alisporivir and its potential in the treatment of hepatitis C
por: Gallay, Philippe A, et al.
Publicado: (2013)

Reaching Hard-to-Reach People Who Use Drugs: A Community-Based Strategy for the Elimination of Hepatitis C
por: Nagot, Nicolas, et al.
Publicado: (2022)

Neuropsychiatric and Psychosocial Issues of Patients With Hepatitis C Infection: A Selective Literature Review
por: Modabbernia, Amirhossein, et al.
Publicado: (2013)

Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review
por: Mravčík, Viktor, et al.
Publicado: (2013)

Improving adherence to hepatitis C screening guidelines
por: Trinh, Jane, et al.
Publicado: (2018)

Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation
por: Meunier, Lucy, et al.
Publicado: (2019)

Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma
por: Merle, Philippe, et al.
Publicado: (2017)

Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort
por: Barré, Tangui, et al.
Publicado: (2022)

Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir
por: Aghemo, Alessio, et al.
Publicado: (2021)

The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges
por: BEHZADIFAR, M., et al.
Publicado: (2020)

Living with hepatitis C, multiple issues to face
por: Coudray, Mathilde, et al.
Publicado: (2012)

Chronic Hepatitis C: Pathophysiology and Clinical Issues
por: Abate, Maria Lorena, et al.
Publicado: (2022)

Correction to: Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir
por: Aghemo, Alessio, et al.
Publicado: (2021)

Faldaprevir for the Treatment of Hepatitis C
por: Kanda, Tatsuo, et al.
Publicado: (2015)

Cyclophilin Inhibitors: An Emerging Class of Therapeutics for the Treatment of Chronic Hepatitis C Infection
por: Hopkins, Sam, et al.
Publicado: (2012)

Clinical Evaluation of Siponimod for the Treatment of Secondary Progressive Multiple Sclerosis: Pathophysiology, Efficacy, Safety, Patient Acceptability and Adherence
por: Sabsabi, Sajida, et al.
Publicado: (2022)

Factors influencing adherence in Hepatitis-C infected patients: a systematic review
por: Mathes, Tim, et al.
Publicado: (2014)

Radiation-Induced Intestinal Normal Tissue Toxicity: Implications for Altered Proteome Profile
por: Larrey, Enoch K., et al.
Publicado: (2022)

Direct patient-physician communication via a hepatitis C hotline facilitates treatment initiation in patients with poor adherence
por: Steininger, Lisa, et al.
Publicado: (2020)

Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting Antivirals
por: Sung, Pil Soo, et al.
Publicado: (2020)

Anti-hepatitis C virus drugs and kidney
por: Carrier, Paul, et al.
Publicado: (2016)

The effect of introducing IGRA to screen French healthcare workers for tuberculosis and potential conclusions for the work organisation
por: Moucaut, Adrien, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_umbpljigmghng3fc9g4ep03nur